These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 1731223)

  • 1. A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension.
    Lifton RP; Dluhy RG; Powers M; Rich GM; Cook S; Ulick S; Lalouel JM
    Nature; 1992 Jan; 355(6357):262-5. PubMed ID: 1731223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase.
    Lifton RP; Dluhy RG; Powers M; Rich GM; Gutkin M; Fallo F; Gill JR; Feld L; Ganguly A; Laidlaw JC
    Nat Genet; 1992 Sep; 2(1):66-74. PubMed ID: 1303253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic screening for glucocorticoid-remediable aldosteronism (GRA): experience of three clinical centres in Poland.
    Adler G; Widecka K; Peczkowska M; Dobrucki T; Placha G; Drozd R; Parczewski M; Januszewicz A; Gaciong Z; Ciechanowicz A
    J Appl Genet; 2005; 46(3):329-32. PubMed ID: 16110193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular basis of glucocorticoid-remediable aldosteronism, a Mendelian cause of human hypertension.
    Lifton RP; Dluhy RG; Powers M; Ulick S; Lalouel JM
    Trans Assoc Am Physicians; 1992; 105():64-71. PubMed ID: 1309006
    [No Abstract]   [Full Text] [Related]  

  • 5. Glucocorticoid-suppressible hyperaldosteronism and adrenal tumors occurring in a single French pedigree.
    Pascoe L; Jeunemaitre X; Lebrethon MC; Curnow KM; Gomez-Sanchez CE; Gasc JM; Saez JM; Corvol P
    J Clin Invest; 1995 Nov; 96(5):2236-46. PubMed ID: 7593610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid-remediable aldosteronism.
    Dluhy RG; Lifton RP
    Endocrinol Metab Clin North Am; 1994 Jun; 23(2):285-97. PubMed ID: 8070423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chimeric gene linked to glucocorticoid-suppressible hyperaldosteronism encodes a fused P-450 protein possessing aldosterone synthase activity.
    Miyahara K; Kawamoto T; Mitsuuchi Y; Toda K; Imura H; Gordon RD; Shizuta Y
    Biochem Biophys Res Commun; 1992 Dec; 189(2):885-91. PubMed ID: 1472060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism.
    Fallo F; Pilon C; Williams TA; Sonino N; Morra Di Cella S; Veglio F; De Iasio R; Montanari P; Mulatero P
    J Hum Hypertens; 2004 Jan; 18(1):47-51. PubMed ID: 14688810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension.
    Jonsson JR; Klemm SA; Tunny TJ; Stowasser M; Gordon RD
    Biochem Biophys Res Commun; 1995 Feb; 207(2):565-71. PubMed ID: 7864844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid-remediable aldosteronism.
    Halperin F; Dluhy RG
    Endocrinol Metab Clin North Am; 2011 Jun; 40(2):333-41, viii. PubMed ID: 21565670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldosterone-producing adenomas do not contain glucocorticoid-remediable aldosteronism chimeric gene duplications.
    Carroll J; Dluhy R; Fallo F; Pistorello M; Bradwin G; Gomez-Sanchez CE; Mortensen R
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4310-2. PubMed ID: 8954032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal salt-wasting and 11 beta-hydroxylase deficiency in a child carrying a homozygous deletion hybrid CYP11B2 (aldosterone synthase)-CYP11B1 (11 beta-hydroxylase).
    Ezquieta B; Luzuriaga C
    Clin Genet; 2004 Sep; 66(3):229-35. PubMed ID: 15324322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation analysis of CYP11B1 and CYP11B2 in patients with increased 18-hydroxycortisol production.
    Nicod J; Dick B; Frey FJ; Ferrari P
    Mol Cell Endocrinol; 2004 Feb; 214(1-2):167-74. PubMed ID: 15062555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic study of patients with dexamethasone-suppressible aldosteronism without the chimeric CYP11B1/CYP11B2 gene.
    Fardella CE; Pinto M; Mosso L; Gómez-Sánchez C; Jalil J; Montero J
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4805-7. PubMed ID: 11600544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and gene mutation studies on a Chinese pedigree with glucocorticoid-remediable aldosteronism.
    Ding W; Liu L; Hu R; Xu M; Chen J
    Chin Med J (Engl); 2002 Jul; 115(7):979-82. PubMed ID: 12150724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Chinese pedigree with glucocorticoid remediable aldosteronism.
    Liu X; Jin L; Zhang H; Ma W; Song L; Zhou X; Cai J
    Hypertens Res; 2021 Nov; 44(11):1428-1433. PubMed ID: 34462604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2.
    Pascoe L; Curnow KM; Slutsker L; Connell JM; Speiser PW; New MI; White PC
    Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8327-31. PubMed ID: 1518866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism.
    Geller DS; Zhang J; Wisgerhof MV; Shackleton C; Kashgarian M; Lifton RP
    J Clin Endocrinol Metab; 2008 Aug; 93(8):3117-23. PubMed ID: 18505761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Low-renin hypertension and inherited mineralocorticoid diseases].
    Kastelan D; Giljević Z; Perković Z; Plavsić V; Breskovac L; Aganović I; Korsić M
    Lijec Vjesn; 1999; 121(7-8):245-9. PubMed ID: 10573960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid-remediable aldosteronism.
    McMahon GT; Dluhy RG
    Cardiol Rev; 2004; 12(1):44-8. PubMed ID: 14667264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.